Szabari Margit V, Ni Chiayi, Davila Diego, Viragh Karoly
From the Department of Radiology, Ronald Reagan UCLA Medical Center, Los Angeles.
Department of Radiology and Nuclear Medicine, Olive View-UCLA Medical Center, Sylmar, CA.
Clin Nucl Med. 2024 Feb 1;49(2):160-161. doi: 10.1097/RLU.0000000000004956. Epub 2023 Nov 17.
A 55-year-old man with renal cell carcinoma extending into the renal vein/inferior vena cava (status post nephrectomy and inferior vena cava thrombectomy, pT3bN0M0), and perioperative pulmonary bland thromboembolism (resolved with 3-month of anticoagulation), followed by 3.5 years of complete remission, developed new incidental pulmonary arterial filling defects on a surveillance CT examination (asymptomatic, normal d -dimer, no deep vein thrombosis). Despite anticoagulation, the filling defects not only persisted but also demonstrated intense FDG activity on a restaging PET/CT performed 4 months later for new pulmonary oligometastasis. The FDG activity resolved after systemic immunotherapy, which suggested the retrospective diagnosis of pulmonary arterial tumor emboli, a rare finding.
一名55岁男性,患有肾细胞癌,肿瘤已延伸至肾静脉/下腔静脉(肾切除及下腔静脉血栓切除术术后,pT3bN0M0),围手术期发生肺单纯性血栓栓塞(经3个月抗凝治疗后缓解),随后完全缓解3.5年,在一次监测CT检查中发现新的偶然的肺动脉充盈缺损(无症状,D -二聚体正常,无深静脉血栓形成)。尽管进行了抗凝治疗,但充盈缺损不仅持续存在,而且在4个月后为评估新的肺寡转移而进行的再分期PET/CT检查中显示出强烈的FDG活性。全身免疫治疗后FDG活性消失,提示回顾性诊断为肺动脉肿瘤栓子,这是一种罕见的发现。